(Journal Article): Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes.
 
Efrat S
 
IN: Ann N Y Acad Sci 1999; 875:286-293
Impact Factor(s) of Ann N Y Acad Sci: 1.789 (2004), 1.892 (2003), 1.682 (2002), 1.593 (2001)

ABSTRACT: The optimal treatment of insulin-dependent diabetes mellitus (IDDM), which is caused by the autoimmune destruction of pancreatic islet beta cells, would require the regulated deliv... Click HERE for details